Global Human Milk Oligosaccharides in Infant Formula Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Human Milk Oligosaccharides in Infant Formula Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global Human Milk Oligosaccharides in Infant Formula market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Human Milk Oligosaccharides (HMOs) are the 3rd most abundant solid component of breast milk after fat and carbohydrates. They feed beneficial bacteria in the gut, where 70% of the immune system exists.

According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China's birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children's consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children's Industry shows that in 80% of families in China, children's expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is ¥17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is ¥485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.

The Global Info Research report includes an overview of the development of the Human Milk Oligosaccharides in Infant Formula industry chain, the market status of Infant Formula (2’FL, 3’FL), Functional Food & Beverages (2’FL, 3’FL), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Human Milk Oligosaccharides in Infant Formula.

Regionally, the report analyzes the Human Milk Oligosaccharides in Infant Formula markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Human Milk Oligosaccharides in Infant Formula market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Human Milk Oligosaccharides in Infant Formula market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Human Milk Oligosaccharides in Infant Formula industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kiloton), revenue generated, and market share of different by Type (e.g., 2’FL, 3’FL).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Human Milk Oligosaccharides in Infant Formula market.

Regional Analysis: The report involves examining the Human Milk Oligosaccharides in Infant Formula market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Human Milk Oligosaccharides in Infant Formula market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Human Milk Oligosaccharides in Infant Formula:

Company Analysis: Report covers individual Human Milk Oligosaccharides in Infant Formula manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Human Milk Oligosaccharides in Infant Formula This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infant Formula, Functional Food & Beverages).

Technology Analysis: Report covers specific technologies relevant to Human Milk Oligosaccharides in Infant Formula. It assesses the current state, advancements, and potential future developments in Human Milk Oligosaccharides in Infant Formula areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Human Milk Oligosaccharides in Infant Formula market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Human Milk Oligosaccharides in Infant Formula market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
2’FL
3’FL
3’SL
6’SL

Market segment by Application
Infant Formula
Functional Food & Beverages
Food/Medical Supplements
Other

Major players covered
Abbott
BASF
Dextra Laboratories
DuPont
Elicityl
Glycom
Glycosyn
Inbiose
Jennewein Biotechnologie
Nestle Health Science
Zuchem

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Human Milk Oligosaccharides in Infant Formula product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Human Milk Oligosaccharides in Infant Formula, with price, sales, revenue and global market share of Human Milk Oligosaccharides in Infant Formula from 2019 to 2024.

Chapter 3, the Human Milk Oligosaccharides in Infant Formula competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Human Milk Oligosaccharides in Infant Formula breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Human Milk Oligosaccharides in Infant Formula market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Human Milk Oligosaccharides in Infant Formula.

Chapter 14 and 15, to describe Human Milk Oligosaccharides in Infant Formula sales channel, distributors, customers, research findings and conclusion.